BIOMAT Database Logo BIOMAT Database Logo

Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virus. 1990

W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
Department of Surgery, University of Heidelberg, Federal Republic of Germany.

Sixteen patients with colorectal carcinoma Dukes' Stage B2, C, or D were treated with an autologous virus-modified tumor-cell vaccine after potential curative tumor resection (R0-Resection). An inoculum of 1 X 10(7) cells incubated with 32 hemagglutination units of nonirradiated Newcastle disease virus (NDV) was given intracutaneously up to four times at 10-day intervals. The delayed-type hypersensitivity (DTH) skin reaction was measured. The vaccination was well tolerated. In 11 of 16 patients an increasing reactivity against the vaccine was observed during the vaccination procedure. A challenge test using autologous tumor cells without NDV after the vaccination cycle revealed a specific antitumor sensibilization in 12 patients. The DTH response was not due to bacterial contamination or sensibility to the virus. Histologic examination of the vaccination site showed a dense infiltration of predominantly helper T-lymphocytes. We conclude that in most of the patients treated active, specific immunization led to a specific antitumor sensitivity.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009522 Newcastle disease virus The most well known avian paramyxovirus in the genus AVULAVIRUS and the cause of a highly infectious pneumoencephalitis in fowl. It is also reported to cause CONJUNCTIVITIS in humans. Transmission is by droplet inhalation or ingestion of contaminated water or food. Avian Paramyxovirus 1,Paramyxovirus 1, Avian
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine.
January 1990, Cancer immunology, immunotherapy : CII,
W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.
January 1996, Clinical cancer research : an official journal of the American Association for Cancer Research,
W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients.
January 1991, European journal of cancer (Oxford, England : 1990),
W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
A modified live Newcastle disease virus vaccine.
October 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial.
January 2009, Cancer immunology, immunotherapy : CII,
W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme.
May 2001, Journal of neuro-oncology,
W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial.
January 1992, Cancer immunology, immunotherapy : CII,
W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
Specific immunotherapy of colorectal carcinoma with Newcastle-disease virus-modified autologous tumor cells prepared from resected liver metastasis.
August 1993, Annals of the New York Academy of Sciences,
W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
Antitumor immunization of head and neck squamous cell carcinoma patients with a virus-modified autologous tumor cell vaccine.
January 2005, Advances in oto-rhino-laryngology,
W Bohle, and P Schlag, and W Liebrich, and P Hohenberger, and M Manasterski, and P Möller, and V Schirrmacher
Active specific immunotherapy with hapten-modified autologous melanoma cell vaccine.
November 1996, Cancer immunology, immunotherapy : CII,
Copied contents to your clipboard!